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In recent years, the development of clinical practice guide-
lines has become a more formalized and ubiquitous process. 
The AGREE II [1, 2] and RIGHT [3] paradigms provide 
instruction for reporting guidelines development; GRADE 
[4] and other systems have been refined for assessing the 
level of evidence and qualifying the strength of recommen-
dations. Nationally recognized authorities such as the NCCN 
[5], professional medical societies with guidelines commit-
tees [6, 7], interdisciplinary working groups, the National 
Guidelines Clearinghouse [8] and successor organizations 
are all playing key roles in developing and disseminating 
guidelines.
The reasons for guideline development are many. Given 
the increased interest in quality of care, guidelines can be 
helpful for educating providers about best practices and 
decreasing variation in care delivery. Guidelines can also 
help introduce new therapies or diagnostic interventions, and 
clarify their role in patient management. Guidelines for rare 
conditions or diseases can spark interest in them and illumi-
nate areas where knowledge is lacking, thereby stimulating 
further research. When high-level evidence is lacking but 
providers need direction, guidelines based largely on expert 
opinion can fill the gap. Payers and regulators can also look 
to guidelines to better understand the standard of care, even 
though guidelines documents typically include a disclaimer 
specifically disavowing any intent to create or reinforce such 
a standard. Even patients can benefit from guidelines, which 
may help them learn about their condition and its common 
management options.
Clinical practice guidelines are general documents 
designed to apply to most affected patients in commonly 
encountered clinical situations. While certain special cir-
cumstances may be envisioned, guidelines are not usually 
intended for situations in which normal care delivery is 
interrupted. Thus, at present, there is a need for a tem-
plate for the adaptation of clinical practice guidelines to 
widespread emergency situations not specifically related 
to the disease or condition addressed by the guidelines. 
Relevant emergencies may be local, regional, national, or 
international. The precise nature of an emergency may 
vary, with possibilities including epidemics or pandemics, 
wars, shortages of medical services or products, natural 
disasters (e.g., earthquakes, fires, floods, droughts), and 
others. The common feature of such emergencies is an 
inability to provide routine care to patients because of 
effects on patients, effects on the health care system, or 
both.
The following is a template for the creation of adapted 
emergency guidance associated with existing clinical 
practice guidelines. This template (PAGE, Principles for 
Adapting Guidelines in Emergencies) is the product of 
the CISTERN (Committee on Invasive Tumor Evidence-
Based Recommendations) [9, 10] group, a multidiscipli-
nary, multispecialty collaboration formed for the purpose 
of cancer guidelines development. The template was 
developed during consensus meetings during March and 
April 2020.
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General rules for emergency guidance
Adapted guidance can be helpful during emergencies and 
times of uncertainty when the normal conditions of care 
delivery are disrupted. Common criteria may facilitate the 
development of any emergency guidance:
 (1) Plan a short timeline to completion. Since an 
emergency implies problematic circumstances that 
are unexpected, patients and providers will not have 
planned for the scenario and will need prompt guid-
ance on how to proceed. Whether a draft guideline is 
needed in hours, days, or weeks, will depend on the 
nature of the specific emergency. Consider contact-
ing other experts to develop the appropriate timeline 
before proceeding. To increase the likelihood that this 
timeline will be observed, it may be prudent to obtain, 
at the inception of the process, written commitments 
from participants to hew to it, and devote appropri-
ate time; those that are unwilling or unable may need 
to be substituted with experts having comparable 
knowledge. Upon invitation, each participant may be 
furnished with a calendar listing dates and times for 
all subsequent meetings, virtual or otherwise, either 
of the entire group or its various subgroups. This will 
help participants prepare, and also facilitate on-time 
completion of the guidelines.
 (2) Consider limited guidance rather than full guide-
lines. The specific emergency likely impacts only 
part of the care delivery process for a particular dis-
ease or condition, and so the emergency direction 
should be limited in scope. There will not be the 
time, resources, or necessity for rigorous guidelines 
development. Instead, emergency guidance can be 
framed as a quick, best-guess, partial solution for a 
pressing problem. Though the best available evidence 
should drive any recommendations, emergency guid-
ance may rely heavily on expert opinion. It is unlikely 
new high-quality studies will be available. Guidance 
should be qualified to make clear to the reader that the 
standard processes for guidelines development were 
either abbreviated or not followed, and as a result, the 
guidance provided is inherently less robust and more 
provisional.
 (3) Define the conditions during which the guidance 
will be in effect. By definition, emergency guidance 
is predicated on the existence of an emergency. While 
the nature of the emergency may be self-evident to 
those preparing the guidance, it is important that the 
relevant conditions prompting the new rules to be 
clearly and precisely delineated in writing to avoid 
any ambiguity. This will preclude any misunderstand-
ing that the emergency guidance is in fact new blanket 
guidance that is always operative. Moreover, charac-
terizing the specific conditions of the emergency, and 
the rationale for the emergency guidance, will also 
make it clear when the emergency comes to an end, 
and the emergency guidance ceases to apply. If the 
end date of an emergency is known at the time the 
emergency guidance is prepared, this date should be 
included in the emergency document as the date of 
expiration.
 (4) Explain how the group developing the guidelines 
was assembled, and use an existing guidelines 
group, if possible. Many professional medical socie-
ties have standing guidelines committees that can be 
mobilized expeditiously. Other national guidelines 
groups may also be well-poised to respond to emer-
gencies. In general, it will be more effective to ask 
members of an existing group to work together to 
develop emergency guidelines than to try to convene 
a new group, as the latter will take time to assemble 
and train. If the expertise within an existing guidelines 
group is insufficient, ad hoc members may be added 
as necessary.
 (5) Use a guidelines group of sufficient size. Since emer-
gency guidance will likely be heavily supported by 
expert opinion rather than high-level published evi-
dence, it is important that the group be of sufficient 
size and diversity to ensure that its recommendations 
are viewed as credible. A small or homogeneously 
constituted group may be viewed as excessively 
swayed by the opinions of individual members, even 
if such bias is inadvertent or unconscious.
 (6) Avoid duplication of the work of other guidelines 
groups. Several different guidelines groups may be 
poised to develop emergency guidance on the same 
topic. Coordination between these groups, if known to 
each other, is best while the others tacitly endorse its 
work product. Multiple, competing sets of dissimilar 
guidances may exacerbate confusion among patients 
and providers.
 (7) Only adopt recommendations supported by con-
sensus or at least a supermajority. When providing 
guidance resting almost solely on expert opinion, it is 
particularly important that this opinion be perceived 
as widely shared. If an existing group is being mobi-
lized to develop emergency guidelines, reasonable 
efforts should be undertaken to include all members 
of this group, as well as other ad hoc invitees with 
relevant expertise. Group consensus is best, but if it 
is unachievable, any recommendations should be sup-
ported by at least a 60% (3/5th) supermajority of all 
group members. Anonymity may be preserved, but a 
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complete vote count (i.e., total number of group mem-
bers, votes in favor, votes against, and abstentions) 
should be posted next to each recommendation. A 
brief rationale shared by those in favor of the recom-
mendation should also be included.
 (8) Convey the tenor and degree of support of dis-
senting views. While views supported by a single 
group member or a very small subgroup need not be 
divulged, dissenting recommendations supported by 
a sizable minority (20% or more) of the group should 
be summarized in the guidance after the majority rec-
ommendation. This is not to detract from the major-
ity recommendations but to concede that a degree of 
uncertainty exists.
 (9) Areas of uncertainty should be acknowledged, and 
issues regarding which no recommendations can be 
provided should be noted. There may be important 
concerns pertaining to the emergency for which no 
clear guidance can be provided due to a very high 
level of associated uncertainty. If this occurs, the 
relevant concerns should be discussed in the guid-
ance document and the lack of agreement regarding 
their management should be explicitly stated. If one 
or more sizable minorities of the group have views 
regarding the management of these concerns, these 
minority opinions and the proportion of the group 
supporting each may be briefly conveyed.
 (10) Do not promulgate recommendations outside the 
specific scope of the guidelines group. Emergen-
cies may arise due to natural or man-made disasters, 
pandemics or pestilence, market forces and market 
failures (e.g., shortages), and civil disobedience 
or armed conflict between nations. Doctors are not 
experts in natural disasters, terrorism, economics, or 
warfare. Indeed, members of a guidelines group will 
lack expertise even in unrelated medical specialties or 
subspecialties. For these reasons, guidance prepared 
by physicians to manage specific diseases and condi-
tions in the context of emergencies should not venture 
into speculating about the nature, causes, duration, or 
course of the underlying emergencies. If it is impor-
tant to discuss safety measures recommended by other 
authorities to cope with the underlying emergency, the 
relevant authorities should be referenced or outside 
consultation sought. Citing appropriate references or 
linking to a webpage may be preferable to attempting 
to reproduce general third-party guidance in a disease-
specific guidance document. By referencing other 
authorities, the guidelines group will avoid inadvert-
ently providing wrong or outdated recommendations.
 (11) Ensure that the final document is brief and easy 
to read. Since emergency guidance is an adaptation 
of existing guidelines, it does not need to be long 
or complex. Apart from the elements that must be 
included (e.g., recommendations, rationale for recom-
mendations, dissenting views, areas of uncertainty), 
the details of the deliberations leading to specific 
recommendations should be omitted or relegated to 
footnotes.
 (12) Widely disseminate the emergency guidance docu-
ment. Patients and physicians may be distracted in 
an emergency situation. Since they may be inundated 
with information excess related to the emergency, they 
may not be aware of the existence of recently pro-
duced emergency guidance. The emergency guidance 
document should thus be proactively disseminated by 
the guidelines group to relevant physicians and car-
egivers through as many communications channels as 
possible. For instance, the emergency guidance may 
be: emailed to caregivers; physically mailed to car-
egivers, if appropriate; presented from the podium at 
live meetings or teleconferences attended by medical 
professionals; sent to professional medical societies 
for posting on their web-pages and for inclusion in 
their news feeds; submitted for expedited publication 
to peer-reviewed journals; and abstracted in non-peer 
reviewed trade publications. Emergency guidance is 
only useful to the extent that it is implemented by 
physicians providing relevant care, and physicians can 
only implement guidance that is readily available, or 
easy to find or download.
 (13) Update the guidance as often as necessary. Emer-
gencies emerge unexpectedly, and they also evolve. 
If conditions associated with an emergency change 
materially, existing emergency guidance may need to 
be updated. Updates should be marked with the time 
and date when they were adopted. Updates should also 
be available in the same repository as all preceding 
guidance and updates, so it is clear to readers which 
is the most recent guidance. If email or other con-
tact information is available for users of the original 
guidance or previous updates, future updates should 
automatically be sent to those to ensure they are not 
unwittingly relying on outdated guidance. After the 
crisis has ended, revisit key guidelines to update the 
relevant disaster planning sections to include the les-
sons learned from the event.
Special considerations based on the type 
of emergency
As noted care-disrupting emergencies can occur when there 
is: damage to physical locations where care is provided; a 
shortage of drugs or devices; a shortage of qualified person-
nel; an excessive number of patients needing care; a situation 
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in which patients are under physical threat or cannot safely 
present to receive care; or a situation in which providers are 
under physical threat or cannot safely deliver care.
Next, we consider specific rules that may help with 
developing emergency guidance in particular types of 
emergencies. For each of these types of emergencies, only 
recommendations specific to the disease or condition being 
considered need be provided in the guidance document. 
Defer to local, state, or national emergency management 
authorities for general guidance on healthcare delivery in 
the context of the emergency.
(1) Damage to physical location, like hospital buildings: 
If appropriate, the emergency guidance document may 
explain how appropriate care for the disease or condi-
tion may need to be delivered in non-medical buildings, 
temporary shelters, or at home.
(2) Shortage of drugs or devices: If appropriate, provide 
suggestions for substituting other drugs or devices for 
managing the disease or condition. For devices, if the 
relevant technical expertise exists among the guidelines 
group, consider designing new, minimally resource-
intensive, and easy-to-fabricate substitutes that may 
be rapidly manufactured.
(3) Shortage of qualified personnel: If appropriate, pro-
vide methods for efficiently training other medical 
personnel to perform the necessary functions for the 
disease or condition. Specify what types of personnel 
and which types of pre-existing job functions may be 
most suitable for retraining.
(4) An excessive number of patients needing care: If 
appropriate, triage patients to minimize overall mor-
bidity and mortality based on a risk assessment of the 
condition or disease and its relevant subcategories. 
Also, identify means that can be used to speed treat-
ment for the disease or condition or to make treatment 
less resource-intensive. Avoid discussion about ration-
ing care or withholding care from more vulnerable sub-
populations as this is an ethically problematic topic for 
physicians.
(5) A situation in which patients are under physical 
threat or cannot safely present to receive care: If 
appropriate, describe alternative strategies for treating 
the disease or condition, including telemedicine, home 
visits, or public health initiatives.
(6) A situation in which providers are under physical 
threat or cannot safely deliver care: If appropriate, 
describe alternative strategies for treating the disease 
or condition, including telemedicine or public health 
initiatives. Referral to a provider in another location 
may be preferable. If traveling by providers is infea-
sible, consider developing methods for training local 
caregivers or family members.
Emergency provisions of general 
(non‑emergency) clinical practice guidelines
While emergency guidance may be necessary, preparing this 
is likely to be resource-intensive and associated with delay. 
Development of even the most efficiently produced emer-
gency guidance will be preceded by the recognition of the 
need for such, assembly of the guidelines group, a consensus 
estimate of how the emergency should alter care delivery, 
and writing and dissemination of the guidance document. 
To mitigate the need for a separate emergency guidance 
document, creators of general (non-emergency) clinical 
guidelines may include a section describing how the main 
guidelines may be adapted in an emergency situation. Since 
the particular type of emergency will not be known at the 
time, this section may stratify potential emergency strate-
gies based on the risk level associated with the emergency. 
In other words, in a dire emergency in which it is extremely 
difficult to deliver care safely, only the care most crucial for 
patients may be provided. In a less extreme emergency, other 
types of care may be feasible.
In summary, emergency guidelines for clinical care of 
particular diseases or conditions may become necessary. 
When possible, advanced planning and anticipatory strate-
gies can be developed to allow for a rapid response. If this 
occurs, abbreviated guidance may be promptly developed 
that is focused specifically on the exigencies of treating this 
disease or condition given the emergency-associated limi-
tations. Such guidance may be most efficiently prepared by 
an existing guidelines group, assuming the group is large 
enough to be viewed as sufficiently diverse and unbiased. 
Vote tallies in favor of individual recommendations should 
be noted in the guidance document, with the views of sizable 
minorities also conveyed. Areas of uncertainty should be 
acknowledged. Specific types of emergencies may warrant 
additional types of specific medical guidance. In all circum-
stances, emergency guidance provided by physicians with 
expertise in a narrow field should avoid advising patients on 
managing the greater emergency.
Funding None.
Compliance with ethical standards 
Conflict of interest The authors declare that they have no conflict of 
interest.
References
 1. Simera I, Moher D, Hirst A, Hoey J, Schulz KF, Altman DG 
(2010) Transparent and accurate reporting increases reliability, 
Archives of Dermatological Research 
1 3
utility, and impact of your research: reporting guidelines and the 
EQUATOR Network. BMC Med 26(8):24
 2. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, 
Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Lit-
tlejohns P, Makarski J, Zitzelsberger L, AGREE Next Steps Con-
sortium (2010) AGREE II: advancing guideline development, 
reporting, and evaluation in health care. Prev Med 51(5):421–424
 3. Chen Y, Yang K, Marušic A, Qaseem A, Meerpohl JJ, Flottorp 
S, Akl EA, Schünemann HJ, Chan ES, Falck-Ytter Y, Ahmed F, 
Barber S, Chen C, Zhang M, Xu B, Tian J, Song F, Shang H, Tang 
K, Wang Q, Norris SL, RIGHT (Reporting Items for Practice 
Guidelines in Healthcare) Working Group (2017) A reporting tool 
for practice guidelines in health care: the RIGHT statement. Ann 
Intern Med 166(2):128–132
 4. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-
Coello P et al (2008) GRADE: an emerging consensus on rating 
quality of evidence and strength of recommendations. BMJ (Clin 
Res Ed) 336(7650):924–926
 5. Chu MB, Slutsky JB, Dhandha MM, Beal BT, Armbrecht ES, 
Walker RJ, Varvares MA, Fosko SW (2014) Evaluation of the 
definitions of “high-risk” cutaneous squamous cell carcinoma 
using the American Joint Committee on Cancer Staging criteria 
and National Comprehensive Cancer Network guidelines. J Skin 
Cancer 2014:154340
 6. Kouba DJ, LoPiccolo MC, Alam M, Bordeaux JS, Cohen B, 
Hanke CW, Jellinek N, Maibach HI, Tanner JW, Vashi N, Gross 
KG, Adamson T, Begolka WS, Moyano JV (2016) Guidelines for 
the use of local anesthesia in office-based dermatologic surgery. 
J Am Acad Dermatol 74(6):1201–1219
 7. Alam M, Gladstone H, Kramer EM, Murphy JP Jr, Nouri K, Neu-
haus IM, Spencer JM, Spenceri E, Van Dyke S, Ceilley RI, Lee 
KK, Menaker G, Monheit GD, Orentreich DS, Raab B, Smith 
KC, Solish NJ, American Society for Dermatologic Surgery 
(2008) ASDS guidelines of care: injectable fillers. Dermatol Surg 
34(1):S115–S148
 8. Munn Z, Qaseem A, American College of Physicians and the 
Joanna Briggs Institute (2018) Disappearance of the National 
Guideline Clearinghouse: a huge loss for evidence-based health 
care. Ann Intern Med 169(9):648–649
 9. Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, 
Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw 
SH, Cartee TV, Chandra S, Cho NL, Choi JN, Council ML, 
Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim 
SF, Jiang SB, Kim J, Kuzel TM, Lai SY, Lawrence N, Lee EH, 
Leitenberger JJ, Maher IA, Mann MW, Minkis K, Mittal BB, 
Nehal KS, Neuhaus IM, Ozog DM, Petersen B, Rotemberg V, 
Samant S, Samie FH, Servaes S, Shields CL, Shin TM, Sobanko 
JF, Somani AK, Stebbins WG, Thomas JR, Thomas VD, Tse DT, 
Waldman AH, Wong MK, Xu YG, Yu SS, Zeitouni NC, Ram-
say T, Reynolds KA, Poon E, Alam M (2019) Sebaceous carci-
noma: evidence-based clinical practice guidelines. Lancet Oncol 
20(12):e699–e714
 10. Worley B, Owen JL, Barker CA, Behshad R, Bichakjian CK, 
Bolotin D, Bordeaux JS, Bradshaw S, Cartee TV, Chandra S, 
Cho N, Choi J, Council ML, Eisen DB, Golda N, Huang CC, 
Ibrahim SF, Jiang SIB, Kim J, Lacutoure M, Lawrence N, Lee 
EH, Leitenberger JJ, Maher IA, Mann M, Minkis K, Mittal B, 
Nehal KS, Neuhaus I, Ozog DM, Petersen B, Samie F, Shin TM, 
Sobanko JF, Somani AK, Stebbins WG, Thomas JR, Thomas V, 
Tse D, Waldman A, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Poon 
E, Alam M (2019) Evidence-based clinical practice guidelines for 
microcystic adnexal carcinoma: informed by a systematic review. 
JAMA Dermatol 155(9):1059–1068
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
Affiliation
Murad Alam1  · Vishnu Harikumar1 · Sarah A. Ibrahim1 · Bianca Y. Kang1 · Ian A. Maher2 · Todd V. Cartee3 · 
Joseph F. Sobanko4 · Nour Kibbi5 · Joshua L. Owen1,31 · Kelly A. Reynolds1 · Diana Bolotin6 · Abigail H. Waldman7 · 
Kira Minkis8 · Brian Petersen9 · M. Laurin Council10 · Kishwer S. Nehal11 · Y. Gloria Xu12 · S. Brian Jiang13 · 
Ally‑Khan Somani14 · Christopher K. Bichakjian15 · Conway C. Huang16 · Daniel B. Eisen17 · David M. Ozog18 · 
Erica H. Lee11 · Faramarz H. Samie19 · Isaac M. Neuhaus20 · Jeremy S. Bordeaux21,22 · Jordan V. Wang23 · 
Justin J. Leitenberger24 · Margaret W. Mann21,22 · Naomi Lawrence25 · Nathalie C. Zeitouni26 · Nicholas Golda27 · 
Ramona Behshad28 · Sherrif F. Ibrahim29 · Siegrid S. Yu20 · Thuzar M. Shin4 · William G. Stebbins30 · Brandon Worley1
1 Department of Dermatology, Feinberg School of Medicine, 
Northwestern University, 676 N St Clair St, Suite 1600, 
Chicago, IL 60611, USA
2 Department of Dermatology, University of Minnesota, 
Minneapolis, MN, USA
3 Department of Dermatology, Penn State College 
of Medicine, Hershey, PA, USA
4 Department of Dermatology, Hospital of the University 
of Pennsylvania, Philadelphia, PA, USA
5 Department of Dermatology, Stanford University School 
of Medicine, Redwood City, CA, USA
6 Section of Dermatology, The University of Chicago, 
Chicago, IL, USA
7 Brigham and Women’s Hospital Department of Dermatology, 
Harvard Medical School, Boston, MA, USA
8 Department of Dermatology, Weill-Cornell Medical College, 
New York, NY, USA
9 Department of Dermatology, Colorado Permanente Medical 
Group, Denver, CO, USA
10 Division of Dermatology, Center for Dermatologic 
and Cosmetic Surgery, Washington University in Saint Louis, 
Saint Louis, MO, USA
 Archives of Dermatological Research
1 3
11 Dermatology Service, Memorial Sloan Kettering Cancer 
Center, New York, NY, USA
12 Department of Dermatology, University 
of Wisconsin-Madison, Madison, WI, USA
13 Department of Dermatology, University of California San 
Diego, San Diego, CA, USA
14 Department of Dermatology, Indiana University School 
of Medicine, Indianapolis, IN, USA
15 Department of Dermatology, University of Michigan, 
Ann Arbor, MI, USA
16 Department of Dermatology, University of Alabama, 
Birmingham, AL, USA
17 Department of Dermatology, University of California Davis, 
Sacramento, CA, USA
18 Department of Dermatology, Henry Ford Hospital, Detroit, 
MI, USA
19 Department of Dermatology, Columbia University Irving 
Medical Center, New York, NY, USA
20 Department of Dermatology, University of California at San 
Francisco, San Francisco, CA, USA
21 Department of Dermatology, Case Western Reserve 
University School of Medicine, Cleveland, OH, USA
22 Department of Dermatology, University Hospitals Cleveland 
Medical Center, Cleveland, OH, USA
23 Laser and Skin Surgery Center of New York, New York, NY, 
USA
24 Department of Dermatology, Oregon Health and Science 
University, Portland, OR, USA
25 Division of Dermatology, Section of Procedural Dermatology, 
Cooper Hospital, Rowan University, Camden, NJ, USA
26 Department of Dermatology, University of Arizona, Phoenix, 
AZ, USA
27 Department of Dermatology, University of Missouri School 
of Medicine, Columbia, MO, USA
28 Department of Dermatology, Saint Louis University School 
of Medicine, Saint Louis, MO, USA
29 Department of Dermatology, University of Rochester, 
Rochester, NY, USA
30 Department of Dermatology, Vanderbilt University Medical 
Center, Nashville, TN, USA
31 South Texas Skin Cancer Center, San Antonio, TX, USA
